Upregulation of c-MET in EGFR TKI gefitinib-resistant HCC827-GR6 xenografts was visualized with a 89Zr-labelled H2 cys-diabody and H2 minibody, with twofold higher uptake observed in resistant tumours [20]. This evidence concerns the gene MET and neoplasm.